AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

AI-Personalized Discharge Education for Patients After Lung Cancer Surgery

RecruitingNAAges 18 Years - 80 YearsAllXiamen University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This randomized controlled trial evaluates the effect of artificial intelligence (AI)-personalized discharge education on discharge teaching quality and recovery outcomes in patients after lung cancer surgery. Eligible participants will be randomly assigned in a 1:1 ratio to either an intervention group or a control group. The control group will receive routine discharge education, including verbal instructions and a standardized printed discharge booklet. The intervention group will receive the same routine education plus an AI-generated personalized discharge guidance plan based on individual clinical and care-related information. All AI-generated content will be reviewed by a responsible nurse before being provided to participants. The primary outcome is the quality of discharge teaching measured on the day of discharge. Secondary outcomes include self-efficacy for postoperative rehab

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Pathologically confirmed primary lung cancer and underwent radical lung cancer surgery by thoracoscopic or open approach, including lobectomy, pneumonectomy, or wedge resection. 2. Age 18 to 80 years. 3. Clinical stage I to III. 4. No distant organ metastasis. 5. Clinically stable after surgery, conscious, and able to perform basic listening, speaking, and reading activities, with planned discharge to home for recovery. 6. The participant or primary caregiver is able to use a smartphone and WeChat. 7. Able and willing to provide informed consent and voluntarily participate in the study. Exclusion Criteria: 1. Recurrent lung cancer or previous treatment with targeted therapy, chemotherapy, or radiotherapy. 2. Severe aphasia, cognitive impairment (MMSE \<24), or psychiatric disorders that prevent independent completion of study questionnaires. 3. Severe cardiac, hepatic, or renal dysfunction, or another malignant tumor. 4. Severe postoperative complications requiring prolonged hospitalization, such as bronchopleural fistula or major bleeding. 5. Participation in another interventional clinical study. 6. Unable to complete the 1-month follow-up because of travel or residence outside the study area after discharge.
๐Ÿ’Š

What it tests

  • AI-Personalized Discharge Education
  • Routine Discharge Education
๐Ÿ“

Where

1 site
Siping Central People's Hospital
Siping, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy